Premier Danielle Smith Directs $200 Million to Expand Cancer Radiotherapy Suites in Calgary and Edmonton

CALGARY — Alberta Premier Danielle Smith and Minister of Health Adriana LaGrange announced on Monday the distribution of $200 million in provincial healthcare capital funding to purchase and install twelve state-of-the-art Magnetic Resonance Linear Accelerator (MR-Linac) systems, robotic radiosurgery suites, and specialized radioligand therapy suites at the Arthur J.E. Child Comprehensive Cancer Centre in Calgary and the Cross Cancer Institute in Edmonton.

The breakthrough clinical radiotherapy technology combines high-resolution diagnostic MRI imaging with high-energy therapeutic radiation beams in real-time, allowing radiation oncologists to visualize tumors as they move during treatment and sculpt radiation doses with sub-millimeter precision, sparing surrounding healthy organs.

Delivering World-Leading Precision Oncology to Albertans Advancements in real-time image-guided radiation allow clinicians to safely deliver higher curative radiation doses in fewer patient sessions—reducing typical five-week prostate or lung cancer treatment courses down to just five outpatient visits.

"Albertans facing a cancer diagnosis deserve access to the most advanced, compassionate, and effective medical technology in the world," Premier Danielle Smith said at the Arthur J.E. Child Comprehensive Cancer Centre in Calgary. "This $200 million investment equips our world-class cancer institutes with precision MR-Linac technology that targets tumors with extraordinary accuracy, dramatically reducing treatment times and side effects so patients can recover and return home to their families."

Clinical Equipment and Research Allocations The $200 million capital program includes:

• 12 MR-Linac & Robotic Radiosurgery Bunkers: $135 million for heavy-radiation-shielded vaults and high-precision radiation delivery systems.
• Targeted Radioligand Cancer Suite Expansion: $40 million for specialized nuclear medicine administration rooms.
• Alberta Cancer Precision Oncology Clinical Trials: $25 million partnering with the University of Calgary and University of Alberta to fund experimental clinical trials for complex pediatric and brain cancers.

Radiation oncologists, medical physicists, and patient advocacy coalitions celebrated the provincial funding, highlighting that precision radiation technology ensures Alberta remains at the forefront of international cancer therapy.